Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Delineating and eradicating cardiovascular inflammageing

Objectif

Atherosclerotic cardiovascular disease remains a leading global cause of morbidity and mortality, driven by inflammageing: a chronic, age-related inflammatory state accelerating atherosclerosis via epigenetic dysregulation in bone marrow immune cells, particularly hematopoietic stem and progenitor cells (HSPCs). Despite therapeutic advances, the precise mechanisms linking inflammageing to atherosclerosis remain underexplored, necessitating innovative approaches to address this escalating health burden in aging populations.

The DEFLAME Program, a cross-disciplinary bioengineering initiative led by Prof. Dr. Willem Mulder, is aimed at delineating the heterogeneous mechanisms of cardiovascular inflammageing across bone marrow niches to guide development of precision mRNA immunotherapy for this insidious process. Leveraging MarrowMap, a novel quantitative tool to map immune cell metabolism across multiple bone marrow niches in mouse models, and our proprietary apolipoprotein nanoparticle (aNP) mRNA delivery platform, DEFLAME integrates nanomedicine, nuclear medicine, hematopoiesis, cardiovascular immunology and multi-omics to achieve two objectives:

O1 To longitudinally and spatially characterize inflammageing in atherosclerosis-accelerated immune aging, myocardial infarction, and intermittent cholesterol exposure models.

O2 To develop aNP-mRNA-based cytokine and checkpoint-directed immunotherapies targeting myeloid (progenitor) cells, with translational evaluation in human cell models.

By combining expertise in nanomedicine, innate immunity, and cardiovascular disease, this high-risk, high-gain ERC Advanced Grant Program seeks to reshape our understanding of immune aging and deliver innovative immunotherapeutics with potential applications beyond cardiovascular disease, including cancer and neurodegenerative disorders, fostering breakthroughs for healthy aging.

Champ scientifique (EuroSciVoc)

Ce projet n'a pas encore été classé par EuroSciVoc.
Proposez les domaines scientifiques qui vous semblent les plus pertinents et aidez-nous à améliorer notre service de classification.

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-ERC - HORIZON ERC Grants

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) ERC-2025-ADG

Voir tous les projets financés au titre de cet appel

Institution d’accueil

TECHNISCHE UNIVERSITEIT EINDHOVEN
Contribution nette de l'UE
€ 1 550 763,75
Adresse
GROENE LOPER 3
5612 AE Eindhoven
Pays-Bas
Région
Zuid-Nederland Noord-Brabant Zuidoost-Noord-Brabant
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée

Bénéficiaires (2)